MediPal Holdings Corporation

DB:59Z Stock Report

Market Cap: €3.2b

MediPal Holdings Future Growth

Future criteria checks 0/6

MediPal Holdings's earnings are forecast to decline at 0.1% per annum while its annual revenue is expected to grow at 2% per year. EPS is expected to decline by 0.2% per annum. Return on equity is forecast to be 6% in 3 years.

Key information

-0.1%

Earnings growth rate

-0.2%

EPS growth rate

Healthcare earnings growth27.5%
Revenue growth rate2.0%
Future return on equity6.0%
Analyst coverage

Good

Last updated06 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:59Z - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20273,771,12738,31643,29964,1864
3/31/20263,679,76135,62440,99061,6226
3/31/20253,619,02636,91972,00092,6666
9/30/20243,604,41546,04756,72572,460N/A
6/30/20243,581,31239,294N/AN/AN/A
3/31/20243,558,73241,47442,44861,843N/A
12/31/20233,507,50537,244N/AN/AN/A
9/30/20233,453,60138,63640,54356,888N/A
6/30/20233,408,41741,724N/AN/AN/A
3/31/20233,360,00838,8062,64216,146N/A
12/31/20223,351,06930,439N/AN/AN/A
9/30/20223,333,07328,22211,52326,954N/A
6/30/20223,304,37228,248N/AN/AN/A
3/31/20223,290,92129,42342,33961,216N/A
12/31/20213,279,58336,411N/AN/AN/A
9/30/20213,265,95130,52325,25945,124N/A
6/30/20213,241,83826,468N/AN/AN/A
3/31/20213,211,12523,92618,78034,448N/A
12/31/20203,208,23726,682N/AN/AN/A
9/30/20203,186,65133,32958,48884,718N/A
6/30/20203,236,31537,002N/AN/AN/A
3/31/20203,253,07937,96829,56556,917N/A
12/31/20193,242,84034,722N/AN/AN/A
9/30/20193,253,49535,44315,49533,428N/A
6/30/20193,189,61334,116N/AN/AN/A
3/31/20193,181,92834,35945,22563,716N/A
12/31/20183,178,57834,315N/AN/AN/A
9/30/20183,169,34434,12255,22475,079N/A
6/30/20183,169,21637,166N/AN/AN/A
3/31/20183,146,31434,780N/A63,558N/A
12/31/20173,124,72433,199N/AN/AN/A
9/30/20173,093,74331,086N/A45,376N/A
6/30/20173,072,59726,239N/AN/AN/A
3/31/20173,063,90029,011N/A47,954N/A
12/31/20163,065,83332,149N/AN/AN/A
9/30/20163,072,86832,201N/A53,535N/A
6/30/20163,057,50133,965N/AN/AN/A
3/31/20163,028,18730,771N/A21,985N/A
12/31/20152,995,21028,449N/AN/AN/A
9/30/20152,953,70726,052N/A25,185N/A
6/30/20152,923,06123,938N/AN/AN/A
3/31/20152,872,90523,687N/A80,466N/A
12/31/20142,902,88922,221N/AN/AN/A
9/30/20142,909,85821,592N/A55,806N/A
6/30/20142,920,80822,231N/AN/AN/A
3/31/20142,947,79825,485N/A-72N/A
12/31/20132,883,61523,157N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 59Z's earnings are forecast to decline over the next 3 years (-0.1% per year).

Earnings vs Market: 59Z's earnings are forecast to decline over the next 3 years (-0.1% per year).

High Growth Earnings: 59Z's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 59Z's revenue (2% per year) is forecast to grow slower than the German market (5.6% per year).

High Growth Revenue: 59Z's revenue (2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 59Z's Return on Equity is forecast to be low in 3 years time (6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y